This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Asia: Oligonucleotide & Peptide Therapeutics
24-26 Feb, 2026
Grand Nikko Tokyo DaibaTokyo

El Djouhar Rekaï, PhD
Process & Analytical Development Director at PolyPeptide Group at PolyPeptide Group
Speaker

Profile

Dr. El Djouhar Rekaï serves as Director of Process & Analytical Development at the PolyPeptide site in Braine-l’Alleud, Belgium. Originally from Paris, Dr. Rekaï earned a Ph.D. in Organic Chemistry, specializing in sugar chemistry, from Pierre and Marie Curie University in 1997. She then completed a postdoctoral fellowship in polymer chemistry at the Université Catholique de Louvain (Belgium) from 1998 to 1999.

In 2000, Dr. Rekaï began her career as a peptide R&D Chemist at UCB Bioproducts. Over the years, she developed a strong expertise in Scaling-up, Industrialization and Process Validation, ultimately taking on responsibility for end-to-end development and manufacturing processes overseeing all clinical phases—from R&D through commercial production—at PolyPeptide (formerly Lonza and UCB Bioproducts).

Agenda Sessions

  • Strategies for Manufacturing of Long and Complex Peptides: Technical Considerations and Case Studies

    9:10am
  • Chairperson’s Remarks: Track 2

    10:55am
  • Chairperson’s Remarks: Track 2

    1:40pm